Clinical Trial: ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Endometrial Cancer
Study Type: INTERVENTIONAL
Official Title: Phase 1 Clinical Trial of ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
Brief Summary:
Endometrial cancer (EC) is the fourth most common cancer in United States women, and alarmingly, the frequency and mortality from EC continues to rise, in part due to the obesity epidemic.Obese women with EC have a 6.3-fold increased risk of death from this disease, as compared to their non-obese counterparts.Patients with advanced/recurrent EC are unlikely to be cured by surgery, conventional chemotherapy (paclitaxel + carboplatin is the standard first-line treatment), radiation, or a combination of…
Read more